Immunoregulatory pathways controlling progression of autoimmunity in NOD mice: The role of CTLA-4 and TGF-β

Annals of the New York Academy of Sciences

Volumn 1150, Issue , 2008, Pages 300-310

  You, Sylvaine ^a,b   Alyanakian, Marie Alexandra ^a,b   Segovia, Berta ^a,b   Damotte, Diane ^c   Bluestone, Jeffrey ^d   Bach, Jean François ^a,b   Chatenoud, Lucienne ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune diabetes; CTLA 4; NOD; Regulatory T cells; TGF

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MEMBRANE RECEPTOR; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AUTOIMMUNITY; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

MUS;

EID: 57749170446     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1447.046     Document Type: Conference Paper

References (33)

1. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 : 531 562.
2. Bluestone, J.A. & A.K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3 : 253 257.
3. Fontenot, J.D. et al. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 : 329 341.
4. Fontenot, J.D., M.A. Gavin & A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 : 330 336.
5. Wildin, R.S. et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27 : 18 20.
6. Takahashi, T. et al. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192 : 303 310.
7. Chen, C. et al. 2006. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281 : 36828 36834.
8. Leibson, P.J. 2004. The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 16 : 328 336.
9. Riley, J.L. & C.H. June. 2005. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 105 : 13 21.
10. Chikuma, S., J.B. Imboden & J.A. Bluestone. 2003. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 197 : 129 135.
11. Schneider, H. et al. 2006. Reversal of the TCR stop signal by CTLA-4. Science 313 : 1972 1975.
12. Berg, M. & N. Zavazava. 2007. Regulation of CD28 expression on CD8+ T cells by CTLA-4. J. Leukoc. Biol.
13. Fallarino, F. et al. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4 : 1206 1212.
14. Oderup, C. et al. 2006. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 118 : 240 249.
15. Peggs, K.S. et al. 2006. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr. Opin. Immunol. 18 : 206 213.
16. Shiraishi, T. et al. 2002. Prevention of acute lung allograft rejection in rat by CTLA4Ig. Am. J. Transplant 2 : 223 228.
17. Waterhouse, P. et al. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 : 985 988.
18. Kuhns, M.S. et al. 2000. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. Proc. Natl. Acad. Sci. USA 97 : 12711 12716.
19. Luhder, F. et al. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187 : 427 432.
20. Read, S., V. Malmstrom & F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192 : 295 302.
21. Read, S. et al. 2006. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177 : 4376 4383.
22. Tang, Q. et al. 2004. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34 : 2996 3005.
23. You, S. et al. 2007. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. USA 104 : 6335 6340.
24. You, S. et al. 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54 : 1415 1422.
25. Herbelin, A. et al. 1998. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J. Immunol. 161 : 2620 2628.
26. Billiard, F. et al. 2006. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J. Immunol. 177 : 2167 2174.
27. Salomon, B. et al. 2000. B7/CD28 Costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12 : 431 440.
28. Chen, W. et al. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 : 1875 1886.
29. Karim, M. et al. 2004. Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J. Immunol. 172 : 923 928.
30. Tisch, R. et al. 2001. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice. J. Immunol. 166 : 6925 6936.
31. You, S. et al. 2004. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J. Immunol. 173 : 6777 6785.
32. Zheng, S.G. et al. 2006. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 176 : 3321 3329.
33. Li, R. et al. 2007. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3 +and CD4 + CD25- TGF-beta 1+ adaptive regulatory T cells. J. Immunol. 179 : 5191 5203.